Prolonged shedding of type 55 human adenovirus in immunocompetent adults with adenoviral respiratory infections.
Kyungmin HuhInseon KimJaehun JungJi Eun LeeByung Woo JhunSe Hun GuDong Hyun SongEun Young LeeHo Jung JeongHongseok YooPublished in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2019)
Human adenovirus (HAdV) is a common pathogen causing respiratory infections with outbreaks reported in the military and community. However, little information is available on the shedding kinetics. We performed a prospective study of immunocompetent adults confirmed with HAdV respiratory infection by multiplex real-time PCR during an outbreak of HAdV-55. Consecutive respiratory specimens of sputum or nasopharyngeal swab were collected from each patient every 2 days. Viral load was measured by real-time quantitative PCR. Of 32 enrolled patients, 27 (84.4%) had pneumonia. Five patients (15.6%) received cidofovir. Viral load was highest in the earliest samples at 8.69 log10 copies/mL. In a linear regression model, viral load declined consistently in a log-linear fashion at the rate of - 0.15 log10 copies/mL per day (95% confidence interval (CI): - 0.18, - 0.12; R2 = 0.32). However, the regression model estimated the viral shedding duration to be 55 days. The rate of decline in viral load did not differ between patients who received cidofovir and who did not. Patients with prominent respiratory symptoms or extensive involvement on chest radiograph had higher volume of viral excretion. Prolonged viral shedding was observed in otherwise healthy adults with HAdV-55 respiratory infection. This finding should be considered in the establishment of infection control and prevention strategies.
Keyphrases
- end stage renal disease
- real time pcr
- endothelial cells
- ejection fraction
- sars cov
- newly diagnosed
- healthcare
- respiratory tract
- prognostic factors
- peritoneal dialysis
- cystic fibrosis
- physical activity
- high resolution
- mass spectrometry
- patient reported outcomes
- acute respiratory distress syndrome
- intensive care unit
- depressive symptoms
- health information
- pluripotent stem cells
- pulmonary tuberculosis
- neural network